Bal Pharma Ltd (BALPHARMA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 555664,
    "name": "Bal Pharma",
    "stock_name": "Bal Pharma",
    "full_name": "Bal Pharma Ltd",
    "name_url": "stocks-analysis/bal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "88.86",
    "chg": 1.25,
    "chgp": "1.43%",
    "dir": 1,
    "prev_price": "87.61",
    "mcapval": "139.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524824,
    "symbol": "BALPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE083D01012",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "35.51 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/bal-pharma-555664-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-4002686",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BalPharmaLtd_mojoScore_4002686.png",
        "date": "2026-05-21 10:10:58",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed below are based on the stock's current position as of 21 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "When is the next results date for Bal Pharma Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-bal-pharma-ltd-3999679",
        "imagepath": "",
        "date": "2026-05-19 23:17:37",
        "description": "The next results date for Bal Pharma Ltd is scheduled for 27 May 2026...."
      },
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3983925",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BalPharmaLtd_mojoScore_3983925.png",
        "date": "2026-05-10 10:10:37",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3967997",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BalPharmaLtd_mojoScore_3967997.png",
        "date": "2026-04-29 10:10:53",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3951889",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BalPharmaLtd_mojoScore_3951889.png",
        "date": "2026-04-18 10:10:38",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Bal Pharma Ltd Falls to 52-Week Low of Rs 64 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-falls-to-52-week-low-amidst-weak-market-and-fundamental-pressures-3920090",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BalPharmaLtd_priceRelatedfactors_3920090.png",
        "date": "2026-03-27 15:05:10",
        "description": "For the fifth consecutive session, Bal Pharma Ltd closed lower, slipping to a fresh 52-week low of Rs 64 on 27 Mar 2026. This decline comes amid a broader market downturn, but the stock’s underperformance remains pronounced compared to its sector and benchmark indices."
      },
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3918904",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BalPharmaLtd_mojoScore_3918904.png",
        "date": "2026-03-27 10:10:27",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 27 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 15,
    "sid": "555664",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/bal-pharma-555664"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "29-May-2026",
      "details": "We are submitting the newspaper advertisements of the Audited financial results ( standalone & Consolidated ) for the quarter and financial year ended 31.03.2026 announced by the Company on 27.05.2026 and published in Financial express (English ) and Sanjayvani ( Kannada) on 29.05.2026.",
      "source": "BSE"
    },
    {
      "caption": "Non Applicability Of Statement Of Deviation & Variation",
      "datetime": "29-May-2026",
      "details": "Filing of Statement of deviation & variation is not applicable to the Company for the quarter ended 31.03.2026.",
      "source": "BSE"
    },
    {
      "caption": "Audited Financial Results-Standalone & Consolidated",
      "datetime": "27-May-2026",
      "details": "Audited financial results of the company for the quarter and financial year ended 31.03.2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bal Pharma Ltd has declared <strong>12%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bal Pharma Ltd is Rated Strong Sell

2026-05-21 10:10:58

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed below are based on the stock's current position as of 21 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

When is the next results date for Bal Pharma Ltd?

2026-05-19 23:17:37

The next results date for Bal Pharma Ltd is scheduled for 27 May 2026....

Bal Pharma Ltd is Rated Strong Sell

2026-05-10 10:10:37

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Bal Pharma Ltd is Rated Strong Sell

2026-04-29 10:10:53

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Bal Pharma Ltd is Rated Strong Sell

2026-04-18 10:10:38

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Bal Pharma Ltd Falls to 52-Week Low of Rs 64 as Sell-Off Deepens

2026-03-27 15:05:10

For the fifth consecutive session, Bal Pharma Ltd closed lower, slipping to a fresh 52-week low of Rs 64 on 27 Mar 2026. This decline comes amid a broader market downturn, but the stock’s underperformance remains pronounced compared to its sector and benchmark indices.

Bal Pharma Ltd is Rated Strong Sell

2026-03-27 10:10:27

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 27 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

View All News